← Open Payments lookup

MAURICE ALISSE: Open Payments

NPI 1730130386 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,607 in 111 payments from 25 companies in 2025. Trend: 2023 $3,434 · 2024 $3,058 · 2025 $2,607

Food & beverage: $2,607
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$570
Lilly USA, LLC14$241
PFIZER INC.11$209
Boehringer Ingelheim Pharmaceuticals, Inc.7$176
Amgen Inc.10$162
Takeda Pharmaceuticals U.S.A., Inc.6$141
Otsuka America Pharmaceutical, Inc.6$136
Axsome Therapeutics, Inc.5$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$125
Bayer Healthcare Pharmaceuticals Inc.5$114

Products named: JARDIANCE, TEZSPIRE, REXULTI, OTEZLA, TRINTELLIX, AIRSUPRA, Auvelity, CAPLYTA.

Industry payments across NY — which companies pay providers there.